Quote | Super Quote
IPO   |   IPO News   |   Listed IPO Information   |   Hot Listed IPO
Stock Code   IPO News IPO Timetable
IPO Detail
02041 麥科田
MEDCAPTAIN
Register Close2026/09/02    IPO Closing in 5 Days
Listing Date2026/09/07
COMPANY PROFILE

Medcaptain Medical Technology Co., Ltd.is a global medical device provider, serving clinical needs across a wide range of clinical departments, wards and offices within medical institutions, as well as community health centers, testing facilities and home care scenarios.

--

The Group medical products are distributed across the APAC, EMEA and AMER regions.  It strategically positioned five R&D centers and six manufacturing centers across China and the UK. It provides reliable sales and after-sales support across multiple time zones.

--

As of March 31, 2026, the Group’s product portfolio included over 60 life support products, 110 minimally invasive intervention products, and 150 in vitro diagnostics products. Its products have cumulatively reached over 140 countries and regions globally. In China, its products have cumulatively reached over 6,000 hospitals, including approximately 90% of Grade 3A hospitals, covering all 31 provinces, municipalities and autonomous regions.

--

Life support medical devices are predominantly utilized in the ICUs, operating rooms and emergency rooms for the management and care of critically ill patients. including medication delivery products, anesthesia machines and vaporizers, and other life support products such as airway management, pulmonary function testing devices, deep vein thrombosis, or DVT, preventive pumps, vein illuminators, monitors, and veterinary life support products. Its minimally invasive intervention products are primarily used in the diagnosis and treatment of conditions relating to the digestive system, including the gastrointestinal and hepatobiliary tracts, and the urological system.

BASIC INFORMATION
MarketHong Kong (Main Board)
Business NatureHealth Care
Major Business AreaGlobal
Board Lot100
GLOBAL OFFERING
No. of Offer Shares38.91M H shares
No. of International Offer Shares35.02M H shares
No. of HK Offer Shares3.89M H shares
Offer Price$15.42
Stock Code2041
Sponsor(s)Morgan Stanley Asia Limited, Huatai Financial Holdings (Hong Kong) Limited
Underwriter(s)Morgan Stanley Asia Limited, Huatai Financial Holdings (Hong Kong) Limited, BNP Paribas Securities (Asia) Limited, Celestial Securities Limited, Eddid Securities and Futures Limited, Futu Securities International (Hong Kong) Limited, Huafu International Securities Limited, Jinluo Securities Limited, SBI China Capital Financial Services Limited, TradeGo Markets Limited, UOB Kay Hian (Hong Kong) Limited, Yuet Sheung International Securities Limited
TIME TABLE
Application PeriodAug 28 (Fri) - noon, Sep 02 (Wed)
Price Determination Date--
Result Announcement DateOn or before Sep 04 (Fri)
Result Announcement DateOn or before Sep 04 (Fri)
Result Announcement DateOn or before Sep 07 (Mon)
Dealings in Shares commence onSep 07, 2026. (Mon)
Reallocation of Shares Offered
Sales Statistics (HKD)
Offer Price$15.42
Capitalization (H Shares)8.31B
NAV / share ($)$2.01 (Unaudited pro forma adj NAV / share)
Use Of Proceeds
Assuming the offer price being at HKD 15.42, the net proceeds raised would be HKD 496.20M, of which
35% : Ongoing and planned R&D to further enrich product lines to build a competitive portfolio
20% : Develop manufacturing centers to expand our production capacity, including investments in production facilities and upgrades of production lines
20% : Enhance sales and marketing capabilities to support scalable business growth
10% : Potential strategic investments and acquisitions
5% : Upgrade IT infrastructure and digital platform
10% : Working capital
Related Document
Remark: The above information is referenced from the prospectus.
  All data is calculated from the non- exercise rights(if applicable).
IPO Calculator
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --
Offer Price︰--
Currency :
Listing Price :
Board Lot :
Admission Fee*
:
Subscribing Lot :
Subscribing Fee :

Subscribing Amount :
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.